Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy.
- DOI
- 10.1016/j.neuroscience.2026.06.011
- Published
- 2026-06-13
- Container
- Neuroscience
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neuroscience.2026.06.011,
title = {Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy.},
author = {Mendoza-Camacho DM and Espinoza-Gutiérrez HA and Viveros-Paredes JM and Flores-Soto ME and Tejeda-Martínez AR.},
year = {2026},
journal = {Neuroscience},
doi = {10.1016/j.neuroscience.2026.06.011},
url = {https://doi.org/10.1016/j.neuroscience.2026.06.011}
}RIS
TY - JOUR TI - Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy. AU - Mendoza-Camacho DM AU - Espinoza-Gutiérrez HA AU - Viveros-Paredes JM AU - Flores-Soto ME AU - Tejeda-Martínez AR. PY - 2026 JO - Neuroscience DO - 10.1016/j.neuroscience.2026.06.011 UR - https://doi.org/10.1016/j.neuroscience.2026.06.011 ER -
APA
DM, M., HA, E., JM, V., ME, F., & AR., T. (2026). Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy.. Neuroscience. https://doi.org/10.1016/j.neuroscience.2026.06.011
Source records
- europe-pmc · retrieved 2026-09-27T02:34:41.922Z